AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIHYDROARTEMISININ+PIPERAQUINE
11 registrations across 3 African markets— 9 active
Markets with DIHYDROARTEMISININ+PIPERAQUINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| P-ALAXIN | 🇬🇭Ghana | GVS PHARMA LIMITED, 102 HYDE PARK SAKI VIHAR ROAD ANDHERI EAST MUMBAI 400072 INDIA | expired | Aug 2026 |
| P-ALAXIN | 🇬🇭Ghana | GVS PHARMA LIMITED, 102 HYDE PARK SAKI VIHAR ROAD ANDHERI EAST MUMBAI 400072 INDIA | active | Aug 2026 |
| P-ALAXIN | 🇬🇭Ghana | GVS PHARMA LIMITED, 102 HYDE PARK SAKI VIHAR ROAD ANDHERI EAST MUMBAI 400072 INDIA | active | Aug 2026 |
| DIPI-ADULT 40MG/320MG FILM COATED BILAYERED TABLET FILM COATED BILAYERED TABLET | 🇲🇼Malawi | — | expired | Jun 2018 |
| D-ARTEPP Dispersible Tablets | 🇹🇿Tanzania | Shanghai Fosun Pharmaceutical Development Co., Ltd | active | — |
| D-ARTEPP Tablets | 🇹🇿Tanzania | Shanghai Fosun Pharmaceutical Development Co., Ltd | active | — |
| Duo-Cotecxin Tablets | 🇹🇿Tanzania | Beijing Holley Cotec Pharmaceuticals Co., Ltd | active | — |
| Ridmal Tablets | 🇹🇿Tanzania | Ajanta Pharma Limited | active | — |
| Duo-Cotecxin Tablets | 🇹🇿Tanzania | Beijing Holley Cotec Pharmaceuticals Co., Ltd | active | — |
| D - Artepp Dispersible Tablet, Dispersible | 🇹🇿Tanzania | Shanghai Fosun Pharmaceutical Development Co., Ltd | active | — |
| D - Artepp Dispersible Tablets | 🇹🇿Tanzania | Shanghai Fosun Pharmaceutical Development Co., Ltd | active | — |
DIHYDROARTEMISININ+PIPERAQUINE in Africa — Regulatory Overview
DIHYDROARTEMISININ+PIPERAQUINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Ghana, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.